Literature DB >> 19909750

Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy.

Hermann Brenner1, Ulrike Haug, Volker Arndt, Christa Stegmaier, Lutz Altenhofen, Michael Hoffmeister.   

Abstract

BACKGROUND & AIMS: Screening colonoscopy is an effective method to reduce the incidence of and mortality from colorectal cancer (CRC). There is little empirical evidence available about the optimal interval for screening, making this a subject of debate. We associated the prevalence of advanced colorectal neoplasms with time since negative colonoscopies.
METHODS: In a study of participants in the German colonoscopy screening program, we determined the prevalence of colorectal neoplasias detected at screening colonoscopy among subjects who had undergone a previous colonoscopy without detection of polyps (negative colonoscopy). Data were compared with that from subjects who had not received colonoscopies.
RESULTS: No CRCs were detected in participants who had a previous negative colonoscopy an average of 11.9 years previously (n = 553), compared with the 8.4 CRC cases expected based on age- and gender-specific prevalences among participants who had not received a colonoscopy (n = 2701; standardized prevalence ratio [SPR] = 0.00; 95% confidence interval [CI]: 0.00-0.55). Prevalence of advanced adenoma was also much lower among subjects who had previous colonoscopies (SPR = 0.42; 95% CI: 0.25-0.68). Adjusted prevalence ratios (95% CIs) for detecting an advanced adenoma were 0.38 (95% CI: 0.16-0.90), 0.34 (95% CI: 0.15-0.74), 0.38 (95% CI: 0.16-0.90), and 0.53 (95% CI: 0.27-1.04) among participants with a negative colonoscopy conducted 1-5, 6-10, 11-15, and >16 years ago, respectively, compared to participants with no previous colonoscopy.
CONCLUSIONS: The low risk of CRC and advanced adenomas after a negative colonoscopy supports suggestions that screening intervals be extended to > or =10 years. Copyright 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19909750     DOI: 10.1053/j.gastro.2009.10.054

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  40 in total

1.  Factors associated with adherence to the recommended postpolypectomy surveillance interval.

Authors:  Eun Ran Kim; Dong Hyun Sinn; Jin Yong Kim; Dong Kyung Chang; Poong-Lyul Rhee; Jae J Kim; Jong Chul Rhee; Young-Ho Kim
Journal:  Surg Endosc       Date:  2012-03-22       Impact factor: 4.584

2.  Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty.

Authors:  Nancy N Baxter; Joan L Warren; Michael J Barrett; Therese A Stukel; V Paul Doria-Rose
Journal:  J Clin Oncol       Date:  2012-06-11       Impact factor: 44.544

Review 3.  Population-based screening for colorectal cancer with faecal occult blood test--do we really have enough evidence?

Authors:  Göran Ekelund; Jonas Manjer; Sophia Zackrisson
Journal:  Int J Colorectal Dis       Date:  2010-07-30       Impact factor: 2.571

4.  How should individuals with a false-positive fecal occult blood test for colorectal cancer be managed? A decision analysis.

Authors:  Ulrike Haug; Amy B Knudsen; Karen M Kuntz
Journal:  Int J Cancer       Date:  2012-03-29       Impact factor: 7.396

5.  The use of an optimized colonoscopy protocol in a low-risk population for colorectal cancer prevention.

Authors:  Swathi Eluri; Seth D Crockett; John A Baron
Journal:  Int J Cancer       Date:  2015-02-24       Impact factor: 7.396

6.  Screening colonoscopy: still the best choice, but for how long?

Authors:  Yoji Takeuchi
Journal:  Dig Dis Sci       Date:  2013-11       Impact factor: 3.199

Review 7.  FIT testing: an overview.

Authors:  Lukejohn W Day; Taft Bhuket; James Allison
Journal:  Curr Gastroenterol Rep       Date:  2013-11

Review 8.  Colorectal Cancer in Inflammatory Bowel Disease.

Authors:  Ryan W Stidham; Peter D R Higgins
Journal:  Clin Colon Rectal Surg       Date:  2018-04-01

9.  Assessing the effectiveness of a cancer screening test in the presence of another screening modality.

Authors:  Jessica Chubak; Rebecca A Hubbard; Eric Johnson; Aruna Kamineni; Carolyn M Rutter
Journal:  J Med Screen       Date:  2014-12-09       Impact factor: 2.136

10.  Colorectal cancer surveillance after index colonoscopy: guidance from the Canadian Association of Gastroenterology.

Authors:  Desmond Leddin; Robert Enns; Robert Hilsden; Carlo A Fallone; Linda Rabeneck; Daniel C Sadowski; Harminder Singh
Journal:  Can J Gastroenterol       Date:  2013-04       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.